consumer health thread, page-16

I think the bids that have left are impatient traders going somewhere else to shuffle a few shekels.

Once we are cash positive which in reality is probably not too far away then fundamental investors will wake up and crunch the numbers and start to take this company seriously as to its potential.Here is the demographic spread for Japan.As you can see there are over 60 Million potential customers for Evolis in the 25 to 65 year age group.Then if you just look at the 15 to 24 age group of young ladies with eyelash flutter issues you have around 6 million potential customers for the Eyelash enhancer coming soon.

Pharma has gone even further and done some calculations on a 1% take up of product in China and the US using the demographics of the countries involved.

I am sure Maria and Dennis are fully aware of these demographic potentials also as will the serious investors once we become cash positive.


0-14 years: 12.84% (male 8,361,611/female 7,875,045)
15-24 years: 9.64% (male 6,417,085/female 5,778,904)
25-54 years: 37.5% (male 23,435,323/female 23,980,781)
55-64 years: 12.15% (male 7,692,424/female 7,665,157)
65 years and over: 27.87% (male 15,397,309/female 19,847,759) (2017 est.)